Data / Form D filings / EIKONOKLASTES THERAPEUTICS, INC.
EIKONOKLASTES THERAPEUTICS, INC.: Form D filing
EIKONOKLASTES THERAPEUTICS, INC., a pharmaceuticals company in Cincinnati, OH, filed a Form D with the SEC in 2026. The latest, on October 6, 2026, reports $16.1 million sold of a $18.6 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2356 PARK AVENUE UNIT 17, Cincinnati, OH, 45206
- Phone
- (513) 549-6484
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1805698
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 6 | Amendment | $18,638,880 | $16,055,106 | $2,583,774 | 15 | Jul 14 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bruce Halpryn | Executive Officer, Director | |
| Samuel Lee | Executive Officer, Director | |
| Kenneth Morand | Director | |
| Thomas Finn | Director | |
| Robert Johnson | Director | |
| Joseph Nolan | Director |
Every Form D from the week of Oct 5 · All recent filings in Ohio · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what EIKONOKLASTES THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.